Evidence map›Paper›PMID 34101141›Full record

ArticlePharmacological reports : PR2021

Correction to: The oxidation and hypoglycaemic effect of sorafenib in streptozotocin-induced diabetic rats.

Agnieszka Karbownik, Anna Stachowiak, Hanna Urjasz, Katarzyna Sobańska, Agnieszka Szczecińska, Tomasz Grabowski, Joanna Stanisławiak-Rudowicz, Anna Wolc, Edmund Grześkowiak, Edyta Szałek

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmacological reports : PR, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Agnieszka KarbownikDepartment of Clinical Pharmacy and Biopharmacy, Poznań University of Medical Sciences, ul. Św. Marii Magdaleny 14, 61-861, Poznan, Poland.ORCID https://orcid.org/0000-0002-3724-0548
Anna StachowiakDepartment of Clinical Pharmacy and Biopharmacy, Poznań University of Medical Sciences, ul. Św. Marii Magdaleny 14, 61-861, Poznan, Poland. stachowiak.an@gmail.com.ORCID https://orcid.org/0000-0001-5006-9303
Hanna UrjaszDepartment of Clinical Pharmacy and Biopharmacy, Poznań University of Medical Sciences, ul. Św. Marii Magdaleny 14, 61-861, Poznan, Poland.ORCID https://orcid.org/0000-0002-5934-484X
Katarzyna SobańskaDepartment of Clinical Pharmacy and Biopharmacy, Poznań University of Medical Sciences, ul. Św. Marii Magdaleny 14, 61-861, Poznan, Poland.
Agnieszka SzczecińskaDepartment of Clinical Pharmacy and Biopharmacy, Poznań University of Medical Sciences, ul. Św. Marii Magdaleny 14, 61-861, Poznan, Poland.
Tomasz GrabowskiPolpharma Biologics SA, ul. Trzy Lipy 3, 80-172, Gdańsk, Poland.ORCID https://orcid.org/0000-0002-3077-9698
Joanna Stanisławiak-RudowiczUniversity Hospital of Lord's Transfiguration, ul. Szamarzewskiego 84/86, Poznan, Poland.
Anna WolcDepartment of Animal Science, Iowa State University, 239E Kildee Hall, Ames, IA, 50011, USA.
Edmund GrześkowiakDepartment of Clinical Pharmacy and Biopharmacy, Poznań University of Medical Sciences, ul. Św. Marii Magdaleny 14, 61-861, Poznan, Poland.ORCID https://orcid.org/0000-0002-9938-6729
Edyta SzałekDepartment of Clinical Pharmacy and Biopharmacy, Poznań University of Medical Sciences, ul. Św. Marii Magdaleny 14, 61-861, Poznan, Poland.ORCID https://orcid.org/0000-0002-3566-6350

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID34101141
PMCPMC8460500

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.